Cargando…
Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis
Polycystic kidney diseases (PKDs) comprise a subgroup of ciliopathies characterized by the formation of fluid-filled kidney cysts and progression to end-stage renal disease. A mechanistic understanding of cystogenesis is crucial for the development of viable therapeutic options. Here, we identify CD...
Autores principales: | Husson, Hervé, Moreno, Sarah, Smith, Laurie A., Smith, Mandy M., Russo, Ryan J., Pitstick, Rose, Sergeev, Mikhail, Ledbetter, Steven R., Bukanov, Nikolay O., Lane, Monica, Zhang, Kate, Billot, Katy, Carlson, George, Shah, Jagesh, Meijer, Laurent, Beier, David R., Ibraghimov-Beskrovnaya, Oxana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081056/ https://www.ncbi.nlm.nih.gov/pubmed/27053712 http://dx.doi.org/10.1093/hmg/ddw093 |
Ejemplares similares
-
Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease
por: Natoli, Thomas A., et al.
Publicado: (2012) -
Polycystic kidney diseases: From molecular discoveries to targeted therapeutic strategies
por: Ibraghimov-Beskrovnaya, O., et al.
Publicado: (2007) -
CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD
por: Bukanov, Nikolay O., et al.
Publicado: (2012) -
Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD
por: Rogers, Kelly A., et al.
Publicado: (2016) -
Correction of cilia structure and function alleviates multi-organ pathology in Bardet–Biedl syndrome mice
por: Husson, Hervé, et al.
Publicado: (2020)